MedPath
NMPA Approval

Eribulin Mesilate Injection

国药准字H20233223

February 28, 2023

Drug Information

甲磺酸艾立布林注射液

注射剂

2ml:1mg

化学药品

February 28, 2023

Company Information

Applicant Company

苏州工业园区星湖街218号C25楼、C26楼、C27楼、C28楼

Manufacturing Company

无锡紫杉药业股份有限公司;博瑞制药(苏州)有限公司

无锡市锡山区东港镇勤新路111号;苏州工业园区江韵路278号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

甲磺酸艾立布林注射液 - NMPA 批准文号 | MedPath